<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T00:02:59Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13021" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13021</identifier><datestamp>2026-10-18T21:13:27Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Changes in antimicrobial resistance and outcomes of health care–associated infections</dc:title><dc:creator>Aydın, Mehtap</dc:creator><dc:creator>Azak, Emel</dc:creator><dc:creator>Bilgin, Hüseyin</dc:creator><dc:creator>Menekse, Sirin</dc:creator><dc:creator>Asan, Ali</dc:creator><dc:creator>Mert, Habibe Tülin Elmaslar</dc:creator><dc:creator>Yulugkural, Zerrin</dc:creator><dc:creator>Altunal, Lutfiye Nilsun</dc:creator><dc:creator>Hatipoğlu, Çiğdem Ataman</dc:creator><dc:creator>Tuncer Ertem, Gunay</dc:creator><dc:creator>Altunok, Elif Sargın</dc:creator><dc:creator>Demirkaya, Melike Hamiyet</dc:creator><dc:creator>Çeviker, Sevil Alkan</dc:creator><dc:creator>Akgul, Fethiye</dc:creator><dc:creator>Memis, Zeynep</dc:creator><dc:creator>Konya, Petek</dc:creator><dc:creator>Azap, Alpay</dc:creator><dc:creator>Aydin, Gule</dc:creator><dc:creator>Korkmaz, Derya</dc:creator><dc:creator>Karakoç, Zehra Çagla</dc:creator><dc:creator>Yapar, Derya</dc:creator><dc:creator>Karakecili, Faruk</dc:creator><dc:creator>Gunal, Ozgur</dc:creator><dc:creator>Keske, Siran</dc:creator><dc:creator>Kapmaz, Mahir</dc:creator><dc:creator>Kader, Cigdem</dc:creator><dc:creator>Demirel, Aslıhan</dc:creator><dc:creator>Ergönül, Önder</dc:creator><dc:subject>associated infections</dc:subject><dc:subject>Blood stream infections</dc:subject><dc:subject>Colistin resistance</dc:subject><dc:subject>Health care</dc:subject><dc:subject>Anti-Bacterial Agents</dc:subject><dc:subject>Antifungal Agents</dc:subject><dc:subject>Bacteremia</dc:subject><dc:subject>Bacteria</dc:subject><dc:subject>Bacterial Infections</dc:subject><dc:subject>Candida</dc:subject><dc:subject>Cross Infection</dc:subject><dc:subject>Drug Resistance, Bacterial</dc:subject><dc:subject>Fungemia</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Mycoses</dc:subject><dc:subject>Retrospective Studies</dc:subject><dc:subject>carbapenem</dc:subject><dc:subject>colistin</dc:subject><dc:subject>meticillin</dc:subject><dc:subject>quinolone</dc:subject><dc:subject>vancomycin</dc:subject><dc:subject>antifungal agent</dc:subject><dc:subject>antiinfective agent</dc:subject><dc:subject>mycosis</dc:subject><dc:subject>Acinetobacter</dc:subject><dc:subject>adult</dc:subject><dc:subject>antibiotic resistance</dc:subject><dc:subject>Article</dc:subject><dc:subject>bloodstream infection</dc:subject><dc:subject>candidiasis</dc:subject><dc:description>To describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.</dc:description><dc:publisher>Springer Science and Business Media Deutschland GmbH</dc:publisher><dc:date>2021</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13021</dc:identifier><dc:identifier>https://doi.org/10.1007/s10096-020-04140-y</dc:identifier><dc:identifier>0934-9723</dc:identifier><dc:language>en</dc:language><dc:relation>European Journal of Clinical Microbiology and Infectious Diseases</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13021</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>